Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Prostate screening and the Forum Against Cancer Europe

Prof Louis Denis - Oncology Centre, Antwerp, Belgium
Prostate screening and the Forum Against Cancer Europe ( Prof Louis Denis - Oncology Centre, Antwerp, Belgium )
17 Nov 2010

Treatment of neuroendocrine tumours with everolimus

Dr Nicola Fazio - European Institute of Oncology, Milan, Italy
Treatment of neuroendocrine tumours with everolimus ( Dr Nicola Fazio - European Institute of Oncology, Milan, Italy )
10 Nov 2010

The development of PARP inhibitors a new drug to treat prostate cancer

Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK
The development of PARP inhibitors a new drug to treat prostate cancer ( Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK )
10 Nov 2010

How to select targeted therapy in renal cancer

Prof Bernard Escudier - Institut Gustave Roussy, Paris, France
How to select targeted therapy in renal cancer ( Prof Bernard Escudier - Institut Gustave Roussy, Paris, France )
10 Nov 2010

Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
10 Nov 2010

Optimal treatment for colorectal cancer patients with liver metastases

Prof Peter Naredi - Umea University, Sweden
Optimal treatment for colorectal cancer patients with liver metastases ( Prof Peter Naredi - Umea University, Sweden )
10 Nov 2010

Bevacizumab as part of standard first line treatment of ovarian cancer

Prof Jonathan Ledermann - University College London, UK
Bevacizumab as part of standard first line treatment of ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
10 Nov 2010

Pain management and the treatment of cancer patients with low blood counts

Prof Dorothy Keefe - The University of Adelaide, Australia
Pain management and the treatment of cancer patients with low blood counts ( Prof Dorothy Keefe - The University of Adelaide, Australia )
10 Nov 2010

GOG-218: Bevacizumab plus standard chemo for ovarian cancer

Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA
GOG-218: Bevacizumab plus standard chemo for ovarian cancer ( Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA )
10 Nov 2010

Implementation of ESMO guidelines

Prof Andrés Cervantes - University of Valencia, Spain
Implementation of ESMO guidelines ( Prof Andrés Cervantes - University of Valencia, Spain )
10 Nov 2010

A multimedia information service for cancer patients

Prof Francesco De Lorenzo - Federico II University of Naples, Italy
A multimedia information service for cancer patients ( Prof Francesco De Lorenzo - Federico II University of Naples, Italy )
10 Nov 2010

A new partnership between OECI and ecancer.tv

Dr Claudio Lombardo - National Institute for Cancer Research of Genoa, Italy and Alleanza Contro il Cancro, Rome, Italy
A new partnership between OECI and ecancer.tv ( Dr Claudio Lombardo - National Institute for Cancer Research of Genoa, Italy and Alleanza Contro il Cancro, Rome, Italy )
10 Nov 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation